Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Seropositive Muscle-Specific Tyrosine Kinase Myasthenia Gravis Presenting as a Late-Onset Isolated Sixth Nerve Palsy: A Case Report and a Brief Review of Subtypes of Myasthenia Gravis. | Cureus | 2021 | 34934570 | PubTator, text mining | PubMed |
| Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. | J Transl Med | 2021 | 34930325 | PubTator, text mining | PubMed |
| miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9. | Evid Based Complement Alternat Med | 2021 | 34925522 | PubTator, text mining | PubMed |
| Efficacy and Safety of Immunotherapies in Refractory Myasthenia Gravis: A Systematic Review and Meta-Analysis. | Front Neurol | 2021 | 34925206 | PubTator, text mining | PubMed |
| [Xihuang Pills and its main components inhibit PI3K/Akt/mTOR signaling pathways and promote the apoptosis of prostate cancer cells in PC-3 tumor-bearing mice]. | Zhonghua Nan Ke Xue | 2021 | 34914218 | PubTator, text mining | PubMed |
| Mechanisms of Congenital Myasthenia Caused by Three Mutations in the COLQ Gene. | Front Pediatr | 2021 | 34912755 | PubTator, text mining | PubMed |
| Antibody-Based Therapeutic Interventions for Amyotrophic Lateral Sclerosis: A Systematic Literature Review. | Front Neurosci | 2021 | 34912191 | PubTator, text mining | PubMed |
| Rituximab in the Management of Refractory Myasthenia Gravis and Variability of Its Efficacy in Anti-MuSK Positive and Anti-AChR Positive Myasthenia Gravis. | Cureus | 2021 | 34909332 | PubTator, text mining | PubMed |
| Competitive endogenous RNA network and pathway-based analysis of LncRNA single-nucleotide polymorphism in myasthenia gravis. | Sci Rep | 2021 | 34907261 | PubTator, text mining | PubMed |
| Chelation therapy in liver diseases of childhood: Current status and response. | World J Hepatol | 2021 | 34904029 | PubTator, text mining | PubMed |
| Recommendations of the AGG (Section Maternal Disease) for Myasthenia Gravis in Pregnancy. | Geburtshilfe Frauenheilkd | 2021 | 34899044 | PubTator, text mining | PubMed |
| A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis. | Int J Mol Sci | 2021 | 34884767 | PubTator, text mining | PubMed |
| Comorbid Autoimmune Diseases in Patients With Myasthenia Gravis: A Retrospective Cross-Sectional Study of a Chinese Cohort. | Front Neurol | 2021 | 34880829 | PubTator, text mining | PubMed |
| Editorial: Molecular Mechanisms Underlying Assembly and Maintenance of the Neuromuscular Junction. | Front Mol Neurosci | 2021 | 34880729 | PubTator, text mining | PubMed |
| [Rituximab for the treatment of generalised myasthenia gravis: experience in clinical practice]. | Rev Neurol | 2021 | 34877644 | PubTator, text mining | PubMed |
| Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response. | Front Immunol | 2021 | 34868026 | PubTator, text mining | PubMed |
| Patients With Myasthenia Gravis With Acute Onset of Dyspnea: Predictors of Progression to Myasthenic Crisis and Prognosis. | Front Neurol | 2021 | 34867753 | PubTator, text mining | PubMed |
| Association Between Myasthenia Gravis and Memory: A Systematic Review and Meta-Analysis. | Front Neurol | 2021 | 34867702 | PubTator, text mining | PubMed |
| Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer. | Front Pharmacol | 2021 | 34867402 | PubTator, text mining | PubMed |
| Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development. | Clin Med Insights Oncol | 2021 | 34866959 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=53